These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Short- and long-term effects of LDL-apheresis on lipoprotein (a) serum levels. Ritter MM; Sühler K; Richter W; Schwandt P Clin Chim Acta; 1990 Dec; 195(1-2):9-15. PubMed ID: 2151209 [TBL] [Abstract][Full Text] [Related]
52. Rationale and study design of a clinical trial to assess the effects of LDL apheresis on proteinuria in diabetic patients with severe proteinuria and dyslipidemia. Wada T; Muso E; Maruyama S; Hara A; Furuichi K; Yoshimura K; Miyazaki M; Sato E; Abe M; Shibagaki Y; Narita I; Yokoyama H; Mori N; Yuzawa Y; Matsubara T; Tsukamoto T; Wada J; Ito T; Masutani K; Tsuruya K; Fujimoto S; Tsuda A; Suzuki H; Kasuno K; Terada Y; Nakata T; Iino N; Kobayashi S Clin Exp Nephrol; 2018 Jun; 22(3):591-596. PubMed ID: 29080119 [TBL] [Abstract][Full Text] [Related]
53. Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells. Cattin L; Petrucco A; Cazzolato G; Bon GB; Borelli V; Nardon E; Zabucchi G; Fonda M; Bordin P ASAIO J; 1997; 43(3):209-13. PubMed ID: 9152493 [TBL] [Abstract][Full Text] [Related]
54. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation. Hughes TA; Gaber AO; Amiri HS; Wang X; Elmer DS; Winsett RP; Hathaway DK; Hughes SM; Ghawji M Metabolism; 1994 Mar; 43(3):333-47. PubMed ID: 8139482 [TBL] [Abstract][Full Text] [Related]
55. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis. Schaedeli F; Uehlinger DE Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839 [TBL] [Abstract][Full Text] [Related]
56. Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: a case report. Ideura T; Hora K; Kaneko Y; Yamazaki T; Tokunaga S; Shigematsu H; Kiyosawa K Transplant Proc; 2000 Feb; 32(1):223-6. PubMed ID: 10701029 [No Abstract] [Full Text] [Related]
57. [Serum lipoprotein (a) levels during treatment with LDL apheresis for homozygous familial hypercholesterolemia]. Lasunción MA; Teruel JL; Alvarez JJ; Gómez-Coronado D; Ortuño J; Herrera E Med Clin (Barc); 1992 Oct; 99(14):541-4. PubMed ID: 1434990 [TBL] [Abstract][Full Text] [Related]
58. Increment of cerebral blood flow by LDL-apheresis in dialysis patients with arteriosclerosis obliterans: a pilot study. Nakajima F; Morimoto S; Yurugi T; Amari Y; Kasuno Y; Fukui M; Furumatsu Y; Kitamura T Int J Artif Organs; 2012 Nov; 35(11):981-5. PubMed ID: 23065872 [TBL] [Abstract][Full Text] [Related]
59. Current status of low-density lipoprotein apheresis treatment for patients with peripheral artery disease and chronic kidney disease in Japanese clinical database. Watanabe Y; Tanaka A; Furuhashi K; Maruyama S Ther Apher Dial; 2023 Dec; 27(6):1000-1009. PubMed ID: 37587685 [TBL] [Abstract][Full Text] [Related]
60. Low-density lipoprotein apheresis for the treatment of refractory hyperlipidemia. Vella A; Pineda AA; O'Brien T Mayo Clin Proc; 2001 Oct; 76(10):1039-46. PubMed ID: 11605688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]